Ethosomes as Promising Novel Transdermal Drug Delivery System and their Therapeutic Applications – A Review
Main Article Content
Abstract
Inadequate penetration of therapeutically active chemicals is the main factor affecting transdermal drug
delivery system networks. The stratum corneum (SC) serves as the skin’s initial line of defense against
drug molecule penetration. To date, this field has employed a number of tactics to overcome the SC barrier
limits. The main purpose of a few innovative methods, including as liposomes, niosomes, ethosomes, and
transfersomes, is to make pharmaceutical and cosmetic substances more permeable through the SC barrier.
The melting point of SC lipids is lowered by ethosomes, which are stable, elastic, nanoscale vesicles with
high phospholipid and ethanol content that interact with the polar head domain of lipid molecules. Finally, it
increases lipid fluidity and cell membrane permeability. This section provides an overview of the most recent
ethosome updates, depending on several pharmacological dose forms, involving gels, patches, and creams.
There is also a brief discussion on updated ethosome patents. To sum up, ethosomes are an ideal vehicle for
the delivery of drugs, cosmetics, and other substances and can be used in place of traditional pharmaceutical
applications.
Downloads
Article Details

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Attribution-Noncommercial 4.0 International License [CC BY-NC 4.0], which requires that reusers give credit to the creator. It allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, for noncommercial purposes only.